Akero Therapeutics, Inc. (AKRO)
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
$2.25B
Dr. Andrew Cheng M.D., Ph.D.
34.00
South San Francisco, CA
Jun 20, 2019
-8.57
$-3.78
7.30
17.25
-83,528.87%
-9.67
2.07
3.11
8,077.44
17.25
-29.02%
-32.52%
Similar stocks (7)
Revolution Medicines, Inc.
RVMD
Madrigal Pharmaceuticals, Inc.
MDGL
Avidity Biosciences, Inc.
RNA
Protagonist Therapeutics, Inc.
PTGX
Inozyme Pharma, Inc.
INZY
Black Diamond Therapeutics, Inc.
BDTX
Passage Bio, Inc.
PASG
ETF Exposure (26)
Invesco DWA Healthcare Momentum ETF
PTH
0.81%
Simplify Health Care ETF
PINK
0.7630979999999999%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.2831744352%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.222%
iShares Biotechnology ETF
IBB
0.18206%
iShares Russell 2000 Value ETF
IWN
0.13064%
iShares Russell 2000 ETF
IWM
0.07678%
ProShares Ultra Nasdaq Biotechnology
BIB
0.06747354966579598%
Schwab U.S. Small-Cap ETF
SCHA
0.0475813874%
iShares Morningstar Small-Cap Growth ETF
ISCG
0.03887%
iShares Morningstar Small-Cap ETF
ISCB
0.03666%
iShares Morningstar Small-Cap Value ETF
ISCV
0.03461%
iShares Russell 2000 Growth ETF
IWO
0.0255%
Fidelity MSCI Health Care Index ETF
FHLC
0.022327990000000002%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.019%
ALPS Medical Breakthroughs ETF
SBIO
0.0138%
ProShares Hedge Replication ETF
HDG
0.012289927927092076%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.01%
Dimensional U.S. Small Cap ETF
DFAS
0.00596482%
iShares Russell 3000 ETF
IWV
0.00422%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00371%
Schwab U.S. Broad Market ETF
SCHB
0.0033952932%
Dimensional U.S. Equity ETF
DFUS
0.00133992%
Dimensional US Core Equity Market ETF
DFAU
5.401799999999999e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.3545e-4%
Vanguard ESG U.S. Stock ETF
ESGV
0%
Similar stocks (7)
Revolution Medicines, Inc.
RVMD
Madrigal Pharmaceuticals, Inc.
MDGL
Avidity Biosciences, Inc.
RNA
Protagonist Therapeutics, Inc.
PTGX
Inozyme Pharma, Inc.
INZY
Black Diamond Therapeutics, Inc.
BDTX
Passage Bio, Inc.
PASG
ETF Exposure (26)
Invesco DWA Healthcare Momentum ETF
PTH
0.81%
Simplify Health Care ETF
PINK
0.7630979999999999%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.2831744352%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.222%
iShares Biotechnology ETF
IBB
0.18206%
iShares Russell 2000 Value ETF
IWN
0.13064%
iShares Russell 2000 ETF
IWM
0.07678%
ProShares Ultra Nasdaq Biotechnology
BIB
0.06747354966579598%
Schwab U.S. Small-Cap ETF
SCHA
0.0475813874%
iShares Morningstar Small-Cap Growth ETF
ISCG
0.03887%
iShares Morningstar Small-Cap ETF
ISCB
0.03666%
iShares Morningstar Small-Cap Value ETF
ISCV
0.03461%
iShares Russell 2000 Growth ETF
IWO
0.0255%
Fidelity MSCI Health Care Index ETF
FHLC
0.022327990000000002%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.019%
ALPS Medical Breakthroughs ETF
SBIO
0.0138%
ProShares Hedge Replication ETF
HDG
0.012289927927092076%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.01%
Dimensional U.S. Small Cap ETF
DFAS
0.00596482%
iShares Russell 3000 ETF
IWV
0.00422%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00371%
Schwab U.S. Broad Market ETF
SCHB
0.0033952932%
Dimensional U.S. Equity ETF
DFUS
0.00133992%
Dimensional US Core Equity Market ETF
DFAU
5.401799999999999e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.3545e-4%
Vanguard ESG U.S. Stock ETF
ESGV
0%